A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Clinical trial NCT06833931 · WITHDRAWN

Trial details

NCT number: NCT06833931
Sponsor: PepGen Inc
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy (DMD)

Start date: 2024-12-17
Primary completion: 2025-05-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.